Banjo Health vs Forus
The two ends of a pharmacy prior authorization, automated separately. Banjo sits inside the plan or pharmacy benefit manager, reading prescriber notes directly and producing a structured recommendation with the evidence attached, backed by certification at the more demanding risk based tier. Forus sits at the point of prescribing, generating and submitting the authorisation, drafting the appeal and routing to pharmacy, free to the provider. Between them a request can now be written by one model and adjudicated by another while a patient waits for a medicine. Neither publishes the number that would show its side is calibrated. And on Forus the question to ask first is who pays, because a free platform routing prescriptions has an economic relationship somewhere in the chain.
- It is pharmacy benefit weighted and reads prescriber notes directly, producing an inspectable structured recommendation with the evidence attached rather than a score.
- Certification is held at the risk based two year tier, which incorporates privacy requirements and is the more demanding assessment.
- For a plan or pharmacy benefit manager, the determination workflow is the constraint and this is built for it.
- It automates the provider's side of the same transaction, generating and submitting the authorisation, drafting appeals and routing to pharmacy, at no cost to the prescriber.
- Coverage is stated as any drug, any insurance, any pharmacy, embedded at the point of prescribing rather than in a back office.
- It states plainly that protected health information is covered under a business associate agreement, alongside a typed attestation.
Side by Side
| Axis | B Banjo Health |
F Forus |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
One of these decides the authorisation and the other submits it, which makes the pair a closed loop with a patient waiting inside it. Neither publishes the calibration number for its side: the proportion of AI informed denials overturned on appeal, and the proportion of automated submissions approved first time.
A product that is free to the provider is paid for by someone else, and in medication access that is usually a manufacturer or pharmacy channel, so establish who funds it and what data flows back. Neither publishes a bias evaluation, in a workflow where the output determines whether a patient starts therapy.